4P Pharma was created in response to the urging need to increase the number of innovative therapeutics entering the developing drug pipeline for cancer and inflammatory diseases. Our team is an important part of the process, combining complementary expertise and seasoned experience in pharmacology, biology, drug development, formulation and translational research. Our founders have decades of experience in maturating early-stage technologies from drug discovery level up to clinical phase IIa in several fields, from medical devices to pharmaceutical and biological compounds, from new chemical entities to generic drug repositioning.